title: Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Palombi
authors.forename: Malgorzata Monika
authors.initials: MM
authors.lastname: Trawinska
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.forename: Marco
authors.initials: M
authors.lastname: Giovannini
authors.forename: Alessio Pio
authors.initials: AP
authors.lastname: Perrotti
authors.forename: Paolo de
authors.initials: Pd
authors.lastname: Fabritiis
authors.forename: Stefano
authors.initials: S
authors.lastname: Fratoni
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008339:Mandibular Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011239:Prednisolone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone